Prevention of DIL primarily involves cautious medication management, particularly among patients with known risk factors. Regular monitoring and patient education about potential symptoms can facilitate early detection and intervention. For patients requiring long-term therapy with drugs known to cause DIL, healthcare providers may consider periodic evaluation of lupus-related symptoms and antibody levels.
